You are here
Prostate Cancer is a disease of the prostate gland, which is found in men below the bladder and in front the rectum. Among Michigan men It is the most commonly diagnosed cancer and the second leading cause of cancer death.
- Age- The biggest risk factor with the majority of cases being diagnosed in men older than 65.
- Race/Ethnicity- Black men are more often diagnosed with prostate cancer than men of other races and are also more likely to die from prostate cancer.
- Family History- Having a father or brother with prostate cancer increases a man’s risk for developing the disease.
The Prostate-Specific Antigen (PSA) test is the most common screening test for prostate cancer.
- The United States Preventive Services Task Force (USPSTF) recommends for men aged 55-69 years to discuss with their provider the benefits and harms of screening.
- It is not clear if PSA screening can help men live longer.
- Harms of screening include false-positive results, over diagnosis, and overtreatment.
There are three standard treatments for early-stage prostate cancer: observation, surgery, and radiation.
- Active surveillance and watchful waiting are two forms of observation. Active surveillance usually includes provider visits with a PSA test every 6 months. Watchful waiting is less intensive and relies on changes in a patient’s symptoms.
- Surgery and radiation are also treatment options, and while they may cure the patient, they may also cause side effects.